PheochromocytomaSymptoms, Doctors, Treatments, Advances & More
Learn About Pheochromocytoma
View Main Condition: Adrenal Cancer
Pheochromocytoma is a rare tumor of adrenal gland tissue that typically arises from the adrenal gland. It results in the release of too much epinephrine and norepinephrine, which are hormones that control heart rate, metabolism, and blood pressure.
Chromaffin tumors; Paraganglionoma
Pheochromocytoma may occur as a single tumor or as more than one growth. It usually develops in the center (medulla) of one or both adrenal glands. The adrenal glands are two triangle-shaped glands. One gland is located on top of each kidney. In rare cases, a pheochromocytoma occurs outside the adrenal gland. When it does, it is usually somewhere else in the abdomen.
Very few pheochromocytomas are cancerous.
The tumors may occur at any age, but they are most common from early to mid-adulthood.
In few instances, the condition may also be seen among family members (hereditary).
Most people with this tumor have attacks of a set of symptoms, which happen when the tumor releases hormones. The attacks usually last from a few minutes to hours. The set of symptoms include:
- Headaches
- Heart palpitations
- Sweating
- High blood pressure
As the tumor grows, the attacks often increase in frequency, length, and severity.
Other symptoms that may occur include:
- Abdominal or chest pain
- Irritability, nervousness
- Pallor
- Weight loss
- Nausea and vomiting
- Shortness of breath
- Seizures
- Problems sleeping
Treatment involves removing the tumor with surgery. It is important to stabilize your blood pressure and pulse with certain medicines before surgery. You may need to stay in the hospital and have your vital signs closely monitored around the time of surgery. After surgery, your vital signs will be continuously monitored in an intensive care unit.
When the tumor cannot be surgically removed, you will need to take medicine to manage it. A combination of medicines is usually needed to control the effects of the extra hormones. Radiation therapy and chemotherapy won't cure this kind of tumor, but they may help control the disease and treat symptoms that arise.
Rogel Cancer Center
Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Elite provider by MediFind in the treatment of Pheochromocytoma. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.
Cleveland Clinic Main Campus
Eren Berber is a General Surgeon practicing medicine in Cleveland, Ohio. Dr. Berber is rated as an Elite provider by MediFind in the treatment of Pheochromocytoma. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Pheochromocytoma, Thyroidectomy, and Parathyroidectomy. Dr. Berber is board certified in American Board Of Surgery, 2006.
Mayo Clinic-Rochester
William Young is an Endocrinologist practicing medicine in Virginia Beach, Virginia. Dr. Young is rated as an Elite provider by MediFind in the treatment of Pheochromocytoma. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Pheochromocytoma, Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1, Adrenal Cancer, and Parathyroidectomy.
Most people who have noncancerous tumors that are removed with surgery are still alive after 5 years. The tumors come back in some people. Levels of the hormones norepinephrine and epinephrine return to normal after surgery.
Continued high blood pressure may occur after surgery. Standard treatments can usually control the high blood pressure.
People who have been successfully treated for pheochromocytoma should have testing from time to time to make sure the tumor has not returned. Close family members may also benefit from testing, because some cases are inherited.
Contact your provider if you:
- Have symptoms of pheochromocytoma, such as headache, sweating, and palpitations
- Had a pheochromocytoma in the past and your symptoms return
Summary: Study in children and adolescents of 177Lu DOTATATE (Lutathera®) combined with the PARP inhibitor olaparib for treatment of recurrent or relapsed solid tumours expressing somatostatin receptors (SSTR) (LuPARPed)
Summary: The purpose of this research study is to find how active and safe 131 I-MIBG is in patients with resistant neuroblastoma, malignant pheochromocytoma and malignant paraganglioma.
Published Date: July 29, 2024
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. Editorial update 02/24/2025.
Cameron J. Endocrine glands. In: Cameron AM, Cameron JL, eds. Current Surgical Therapy. 14th ed. Philadelphia, PA: Elsevier; 2023:Sect 13, 809-894.
National Cancer Institute website. Pheochromocytoma and paraganglioma treatment (PDQ) - health professional version. www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_38_toc. Updated November 1, 2024. Accessed February 24, 2025.
Pacak K, Timmers HJLM, Taieb D, Lenders JWM, Eisenhofer G. Pheochromocytoma. In: Robertson RP, Giudice LC, Grossman AB, Hammer GD, Jensen MD, Kahaly GJ, et al, eds. DeGroot's Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 99.